Browse > Article
http://dx.doi.org/10.5090/jcs.22.057

Indications for Lung Transplantation and Patient Selection  

Son, Joohyung (Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital)
Shin, Changwon (Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital)
Publication Information
Journal of Chest Surgery / v.55, no.4, 2022 , pp. 255-264 More about this Journal
Abstract
Globally, thousands of patients undergo lung transplantation owing to end-stage lung disease each year. As lung transplantation evolves, recommendations and indications are constantly being updated. In 2021, the International Society for Heart and Lung Transplantation published a new consensus document for selecting candidates for lung transplantation. However, it is still difficult to determine appropriate candidates for lung transplantation among patients with complex medical conditions and various diseases. Therefore, it is necessary to analyze each patient's overall situation and medical condition from various perspectives, and ongoing efforts to optimize the analysis will be necessary. The purpose of this study is to review the extant literature and discuss recent updates.
Keywords
Lung transplantation; Chronic obstructive pulmonary disease; Idiopathic pulmonary fibrosis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Fukahara K, Minami K, Hansky B, et al. Successful heart-lung transplantation in a patient with kyphoscoliosis. J Heart Lung Transplant 2003;22:468-73.   DOI
2 Kuntz K, Weinland SR, Butt Z. Psychosocial challenges in solid organ transplantation. J Clin Psychol Med Settings 2015;22:122-35.   DOI
3 Valapour M, Lehr CJ, Skeans MA, et al. OPTN/SRTR 2017 annual data report: lung. Am J Transplant 2019;19 Suppl 2:404-84.   DOI
4 Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824.   DOI
5 Newton CA, Batra K, Torrealba J, et al. Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive. Eur Respir J 2016;48:1710-20.   DOI
6 Delanote I, Wuyts WA, Yserbyt J, Verbeken EK, Verleden GM, Vos R. Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series. BMC Pulm Med 2016;16:156.   DOI
7 Chambers DC, Cherikh WS, Harhay MO, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult lung and heartlung transplantation report-2019; focus theme: donor and recipient size match. J Heart Lung Transplant 2019;38:1042-55.   DOI
8 Jacob J, Bartholmai BJ, Rajagopalan S, et al. Predicting outcomes in idiopathic pulmonary fibrosis using automated computed tomographic analysis. Am J Respir Crit Care Med 2018;198:767-76.   DOI
9 Morlacchi LC, Greer M, Tudorache I, et al. The burden of sinus disease in cystic fibrosis lung transplant recipients. Transpl Infect Dis 2018;20:e12924.   DOI
10 Woll F, Mohanka M, Bollineni S, et al. Characteristics and outcomes of lung transplant candidates with preexisting renal dysfunction. Transplant Proc 2020;52:302-8.   DOI
11 Titman A, Rogers CA, Bonser RS, Banner NR, Sharples LD. Disease-specific survival benefit of lung transplantation in adults: a national cohort study. Am J Transplant 2009;9:1640-9.   DOI
12 Kreider M, Hadjiliadis D, Kotloff RM. Candidate selection, timing of listing, and choice of procedure for lung transplantation. Clin Chest Med 2011;32:199-211.   DOI
13 Sole A, Garcia-Robles AA, Jorda C, et al. Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection. Am J Transplant 2018;18:504-9.   DOI
14 Chambers DC, Perch M, Zuckermann A, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-eighth adult lung transplantation report - 2021; focus on recipient characteristics. J Heart Lung Transplant 2021;40:1060-72.   DOI
15 Leard LE, Holm AM, Valapour M, et al. Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2021;40:1349-79.   DOI
16 Lehr CJ, Blackstone EH, McCurry KR, Thuita L, Tsuang WM, Valapour M. Extremes of age decrease survival in adults after lung transplant. Chest 2020;157:907-15.   DOI
17 Inci I, Iskender I, Ehrsam J, et al. Previous lung volume reduction surgery does not negatively affect survival after lung transplantation. Eur J Cardiothorac Surg 2018;53:596-602.   DOI
18 Dobbels F, Vanhaecke J, Dupont L, et al. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation 2009;87:1497-504.   DOI
19 Kern RM, Seethamraju H, Blanc PD, et al. The feasibility of lung transplantation in HIV-seropositive patients. Ann Am Thorac Soc 2014;11:882-9.   DOI
20 Halloran K, Aversa M, Tinckam K, et al. Comprehensive outcomes after lung retransplantation: a single-center review. Clin Transplant 2018;32:e13281.   DOI
21 Al-Adra DP, Hammel L, Roberts J, et al. Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: a consensus expert opinion statement. Am J Transplant 2021;21:475-83.   DOI
22 Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016;37:67-119.   DOI
23 Criner GJ, Delage A, Voelker K, et al. Improving lung function in severe heterogenous Emphysema with the Spiration Valve System (EMPROVE): a multicenter, open-label randomized controlled clinical trial. Am J Respir Crit Care Med 2019;200:1354-62.   DOI
24 Rosenberger EM, DiMartini AF, DeVito Dabbs AJ, et al. Psychiatric predictors of long-term transplant-related outcomes in lung transplant recipients. Transplantation 2016;100:239-47.   DOI
25 Balasubramanian A, MacIntyre NR, Henderson RJ, et al. Diffusing capacity of carbon monoxide in assessment of COPD. Chest 2019;156:1111-9.   DOI
26 Dew MA, Rosenberger EM, Myaskovsky L, et al. Depression and anxiety as risk factors for morbidity and mortality after organ transplantation: a systematic review and meta-analysis. Transplantation 2015;100:988-1003.   DOI
27 National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. Washington (DC): National Academies Press (US); 2017.
28 Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12.   DOI
29 Bavaria JE, Pochettino A, Kotloff RM, et al. Effect of volume reduction on lung transplant timing and selection for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1998;115:9-18.   DOI
30 Amano M, Izumi C, Baba M, et al. Progression of right ventricular dysfunction and predictors of mortality in patients with idiopathic interstitial pneumonias. J Cardiol 2020;75:242-9.   DOI
31 Kishaba T, McGill R, Nei Y, et al. Clinical characteristics of dermatomyosits/polymyositis associated interstitial lung disease according to the autoantibody. J Med Invest 2018;65:251-7.   DOI
32 Ramos KJ, Quon BS, Heltshe SL, et al. Heterogeneity in survival in adult patients with cystic fibrosis with FEV1 < 30% of predicted in the United States. Chest 2017;151:1320-8.   DOI
33 Hayes D Jr, Kopp BT, Tobias JD, et al. Survival in patients with advanced non-cystic fibrosis bronchiectasis versus cystic fibrosis on the waitlist for lung transplantation. Lung 2015;193:933-8.   DOI
34 Ando K, Okada Y, Akiba M, et al. Lung transplantation for lymphangioleiomyomatosis in Japan. PLoS One 2016;11:e0146749.   DOI
35 Khawar MU, Yazdani D, Zhu Z, Jandarov R, Dilling DF, Gupta N. Clinical outcomes and survival following lung transplantation in patients with lymphangioleiomyomatosis. J Heart Lung Transplant 2019;38:949-55.   DOI
36 Cypel M, Keshavjee S. When to consider lung transplantation for COVID-19. Lancet Respir Med 2020;8:944-6.   DOI
37 Al-Adra DP, Hammel L, Roberts J, et al. Pretransplant solid organ malignancy and organ transplant candidacy: a consensus expert opinion statement. Am J Transplant 2021;21:460-74.   DOI
38 Souza SM, Nakasato M, Bruno ML, Macedo A. Nutritional profile of lung transplant candidates. J Bras Pneumol 2009;35:242-7.   DOI
39 Kurosaki T, Otani S, Miyoshi K, et al. Favorable survival even with high disease-specific complication rates in lymphangioleiomyomatosis after lung transplantation-long-term follow-up of a Japanese center. Clin Respir J 2020;14:116-23.   DOI
40 Bharat A, Querrey M, Markov NS, et al. Lung transplantation for patients with severe COVID-19. Sci Transl Med 2020;12:eabe4282.   DOI
41 Kon ZN, Dahi S, Evans CF, et al. Long-term venovenous extracorporeal membrane oxygenation support for acute respiratory distress syndrome. Ann Thorac Surg 2015;100:2059-63.   DOI
42 Davis RD Jr, Lau CL, Eubanks S, et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 2003;125:533-42.   DOI
43 Chen H, Shiboski SC, Golden JA, et al. Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension. Am J Respir Crit Care Med 2009;180:468-74.   DOI
44 Benza RL, Gomberg-Maitland M, Elliott CG, et al. Predicting survival in patients with pulmonary arterial hypertension: the REVEAL Risk Score Calculator 2.0 and comparison with ESC/ERS-based risk assessment strategies. Chest 2019;156:323-37.   DOI
45 Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019;53:1801913.   DOI
46 Hayanga AJ, Aboagye JK, Hayanga HE, et al. Contemporary analysis of early outcomes after lung transplantation in the elderly using a national registry. J Heart Lung Transplant 2015;34:182-8.   DOI
47 Singer JP, Peterson ER, Snyder ME, et al. Body composition and mortality after adult lung transplantation in the United States. Am J Respir Crit Care Med 2014;190:1012-21.   DOI
48 Rosenberg AA, Haft JW, Bartlett R, et al. Prolonged duration ECMO for ARDS: futility, native lung recovery, or transplantation? ASAIO J 2013;59:642-50.   DOI
49 Upala S, Panichsillapakit T, Wijarnpreecha K, Jaruvongvanich V, Sanguankeo A. Underweight and obesity increase the risk of mortality after lung transplantation: a systematic review and meta-analysis. Transpl Int 2016;29:285-96.   DOI
50 Jomphe V, Mailhot G, Damphousse V, et al. The impact of waiting list BMI changes on the short-term outcomes of lung transplantation. Transplantation 2018;102:318-25.   DOI
51 Shah N, Force SD, Mitchell PO, et al. Gastroesophageal reflux disease is associated with an increased rate of acute rejection in lung transplant allografts. Transplant Proc 2010;42:2702-6.   DOI
52 Ramos KJ, Kapnadak SG, Bradford MC, et al. Underweight patients with cystic fibrosis have acceptable survival following lung transplantation: a United Network for Organ Sharing Registry Study. Chest 2020;157:898-906.   DOI
53 Degen DA, Janardan J, Barraclough KA, et al. Predictive performance of different kidney function estimation equations in lung transplant patients. Clin Biochem 2017;50:385-93.   DOI
54 Khandhar SJ, Althouse AD, Mulukutla S, et al. Postoperative outcomes and management strategies for coronary artery disease in patients in need of a lung transplantation. Clin Transplant 2017;31:e13026.   DOI
55 Murthy SC, Nowicki ER, Mason DP, et al. Pretransplant gastroesophageal reflux compromises early outcomes after lung transplantation. J Thorac Cardiovasc Surg 2011;142:47-52.   DOI
56 Blondeau K, Mertens V, Vanaudenaerde BA, et al. Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J 2008;31:707-13.   DOI
57 Canton-Bulnes ML, Hurtado Martinez A, Lopez-Cerero L, Arenzana Seisdedos A, Merino-Bohorquez V, Garnacho-Montero J. A case of pan-resistant Burkholderia cepacia complex bacteremic pneumonia, after lung transplantation treated with a targeted combination therapy. Transpl Infect Dis 2019;21:e13034.   DOI
58 Benazzo A, Schwarz S, Frommlet F, et al. Twenty-year experience with extracorporeal life support as bridge to lung transplantation. J Thorac Cardiovasc Surg 2019;157:2515-25.   DOI
59 Perez AA, Singer JP, Schwartz BS, et al. Management and clinical outcomes after lung transplantation in patients with pre-transplant Mycobacterium abscessus infection: a single center experience. Transpl Infect Dis 2019;21:e13084.   DOI
60 Mason DP, Thuita L, Nowicki ER, Murthy SC, Pettersson GB, Blackstone EH. Should lung transplantation be performed for patients on mechanical respiratory support?: the US experience. J Thorac Cardiovasc Surg 2010;139:765-73.   DOI
61 Hoetzenecker K, Donahoe L, Yeung JC, et al. Extracorporeal life support as a bridge to lung transplantation-experience of a high-volume transplant center. J Thorac Cardiovasc Surg 2018;155:1316-28.   DOI
62 Halloran K, Hirji A, Li D, et al. Coronary artery disease and coronary artery bypass grafting at the time of lung transplantation do not impact overall survival. Transplantation 2019;103:2190-5.   DOI
63 Plochl W, Pezawas L, Artemiou O, Grimm M, Klepetko W, Hiesmayr M. Nutritional status, ICU duration and ICU mortality in lung transplant recipients. Intensive Care Med 1996;22:1179-85.   DOI
64 Banga A, Mohanka M, Mullins J, et al. Characteristics and outcomes among patients with need for early dialysis after lung transplantation surgery. Clin Transplant 2017;31:e13106.   DOI
65 Sherman W, Rabkin DG, Ross D, et al. Lung transplantation and coronary artery disease. Ann Thorac Surg 2011;92:303-8.   DOI
66 Chaikriangkrai K, Jyothula S, Jhun HY, et al. Impact of pre-operative coronary artery disease on cardiovascular events following lung transplantation. J Heart Lung Transplant 2016;35:115-21.   DOI
67 Alvarez-Lopez P, Riveiro-Barciela M, Oleas-Vega D, et al. Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients. Medicine (Baltimore) 2020;99:e19407.   DOI
68 Verleden SE, Todd JL, Sato M, et al. Impact of CLAD phenotype on survival after lung retransplantation: a multicenter study. Am J Transplant 2015;15:2223-30.   DOI
69 Su JW, Mason DP, Murthy SC, et al. Successful double lung transplantation in 2 patients with severe scoliosis. J Heart Lung Transplant 2008;27:1262-4.   DOI